Walleye Trading
CBIO

Walleye Trading’s Crescent Biopharma CBIO Stock Holding History

Walleye Trading’s Portfolio CBIO Stock Details CBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-189
Closed -$71K – 4312
2020
Q2 		$71K Sell
189
-376
-67% -$106K ﹤0.01% 3673
2020
Q1 		$129K Buy
+565
New +$216K ﹤0.01% 2943
2019
Q4 		– Sell
-300
Closed -$129K – 4392
2019
Q3 		$129K Buy
+300
New +$193K ﹤0.01% 3207
2016
Q3 		– Sell
-47
Closed -$34K – 5049
2016
Q2 		$34K Buy
47
+46
+4,600% +$31.7K ﹤0.01% 4240
2016
Q1 		$1K Buy
+1
New +$513 ﹤0.01% 5183

Other funds holding CBIO

NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Walleye Trading's CBIO Position: Q3 2020 in Review

Walleye Trading sold out of Crescent Biopharma (CBIO) in Q3 2020, closing a stake of 189 shares — an estimated $71K sold.

Walleye Trading first reported a position in CBIO in Q1 2016 and held it in 5 quarters. The position peaked at $129K in Q1 2020. 80 funds tracked by Wall St. Rank hold CBIO as of Q3 2020.

  • Walleye Trading reported no remaining Crescent Biopharma position as of Q3 2020 after selling out during the quarter.
  • Walleye Trading sold 189 Crescent Biopharma shares in Q3 2020, an estimated $71K.
  • Walleye Trading first reported a position in Crescent Biopharma in Q1 2016 and held it in 5 quarters.
  • Walleye Trading's Crescent Biopharma position peaked at $129K in Q1 2020.
  • 80 funds tracked by Wall St. Rank held Crescent Biopharma as of Q3 2020.

Based on Walleye Trading's 13F filing for Q3 2020, filed 16 Nov 2020.